Pathogens - NuvaWave™

“We’re combating the pathogens
of today and tomorrow”

The Impact of Hospital Acquired Infections

At any given time, about 1 in 25 US patients will contract at least one infection during a hospital stay.
An estimated 1.7 million infections and nearly 700,000 associated deaths each year
Bacteria alone cause about 90% of HAIs
US hospitals spend $45 billion each year treating HAIs
Cleaning practices decontaminate only 50% of problem surfaces

Efficacy:

NuvaWave has a critical role to play in ensuring the integrity of the places we trust to help us stay well and healthy, not just during this time of COVID, but always.

The Texas Biomedical Research Institute recently completed an independent testing on the efficacy of NuvaWave in killing SARS-CoV-2. They demonstrated that NuvaWave killed 99.98% of the virus in 2 seconds. No other UV device in the world has demonstrated these types of results with an independent 3rd party.

Hospitals must be continually cleaned to remain safe. Every hour after a terminal clean the bioburden of a hospital room increases, creating a gap for pathogens to grow and endanger patients.

3rd Party Testing Results

NuvaWave™ is engineered to deliver the best performance on the market. That means shorter cycles, higher efficacy, and safer spaces than competitors. Efficacy testing shows that NuvaWave™ can destroy over 99.98% of the most common and harmful pathogens in just 2 seconds.

SARS-CoV-2

99.98% in 2 seconds

Methicillin-Resistant Staphylococcus Aureus (MRSA)

99.94% in 2 seconds

Acinetobacter baumannii

99.99% in 2 seconds

Escherichia coli

99.99% in 2 seconds

Enterococci Faecalis

99.999% in 2 seconds

Klebsiella pneumoniae